Monashee Scales Back Structure: GPCR Bet Reassessed
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
See what results to expect from zero based budgeting and how to monitor progress with clear, actionable metrics.
19,375 articlesA major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
A notable weekly move in the stock market often comes from a mix of policy signals, earnings notes, and sector moment...
Two Invesco health care ETFs offer different paths to play the GLP-1 revolution. This guide breaks down how invesco's...
Investors watched the barnes noble education stock surge as earnings signals mixed. This guide breaks down what drove...
AI data centers are pushing bandwidth limits, lifting demand for photonics. This report examines five notable players...
When a MongoDB director sells a sizable block of shares, investors pause to weigh the meaning. This article breaks do...
Veeva Systems prepares to unveil Q4 FY2026 after the bell, with investors weighing durable renewals against software ...
A prominent investor dumped a multi‑million stake in a biotech stock that’s up double digits. This article explains w...
Airbnb (ABNB) enters 2026 with evolving monetization and travel demand. This guide breaks down Q1 insights, margins, ...
As defense demand accelerates, Anduril Industries partnering with Rocket Lab to tackle hypersonics could reshape fund...
Uncover five key quotes from AMD's earnings call and what they could mean for the stock in 2026. Learn how to transla...
Could Lilly ride a Nvidia-like surge? This piece analyzes whether the stock can follow Nvidia’s AI-driven momentum, f...